Lumantad, Ahsen .
HRN: 26-18-31 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2024
MUPIROCIN 2%, 15G (TUBE)
11/06/2024
11/13/2024
TOPICAL
1 Squint
Bid
Skin Lesions
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes